Insider Trades52 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | Sell | AQST | Sherry Korczynski | Chief Commercial Officer | 2,714 | $4.25 | $599.9M | -36.69% | +63.14% | $11.5K | -1.14% | — | Buy Now |
| Jul 15, 2026 | Sell | AQST | Daniel Barber | President and CEO | 25,000 | $4.01 | $599.9M | -36.69% | +63.14% | $100.2K | -1.97% | — | Buy Now |
| Jun 15, 2026 | Sell | AQST | Daniel Barber | President and CEO | 25,000 | $4.16 | $599.9M | -36.69% | +63.14% | $104.0K | -3.78% | — | Buy Now |
| Jun 8, 2026 | Sell | AQST | Sherry Korczynski | Chief Commercial Officer | 2,714 | $3.91 | $599.9M | -36.69% | +63.14% | $10.6K | -1.13% | — | Buy Now |
| May 15, 2026 | Sell | AQST | Melina Cioffi | SVP, Regulatory Affairs | 1,667 | $4.17 | $599.9M | -36.69% | +63.14% | $7.0K | -0.61% | — | Buy Now |
| May 15, 2026 | Sell | AQST | Daniel Barber | President and CEO | 8,257 | $4.29 | $599.9M | -36.69% | +63.14% | $35.4K | -1.23% | — | Buy Now |
| May 7, 2026 | Sell | AQST | Lori J Braender | Corporate Secretary | 135,690 | $4.23 | $599.9M | -36.69% | +63.14% | $574.0K | -37.00% | — | Buy Now |
| May 5, 2026 | Sell | AQST | Peter E. Boyd | Chief People Officer | 56,778 | $4.18 | $599.9M | -36.69% | +63.14% | $237.3K | -16.77% | — | Buy Now |
| May 5, 2026 | Sell | AQST | Cassie Jung | Chief Operating Officer | 72,734 | $4.18 | $599.9M | -36.69% | +63.14% | $304.0K | -26.45% | — | Buy Now |
| May 5, 2026 | Sell | AQST | Lori J Braender | Corporate Secretary | 76,147 | $4.18 | $599.9M | -36.69% | +63.14% | $318.3K | -17.19% | — | Buy Now |
| May 5, 2026 | Sell | AQST | A Ernest Jr Toth | Chief Financial Officer | 92,652 | $4.18 | $599.9M | -36.69% | +63.14% | $387.3K | -24.63% | — | Buy Now |
| May 5, 2026 | Sell | AQST | Daniel Barber | President and CEO | 335,922 | $4.18 | $599.9M | -36.69% | +63.14% | $1.4M | -33.43% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | Sherry Korczynski | Chief Commercial Officer | 15,741 | $4.17 | $599.9M | -36.69% | +63.14% | $65.7K | -5.26% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | Melina Cioffi | SVP, Regulatory Affairs | 25,311 | $4.17 | $599.9M | -36.69% | +63.14% | $105.6K | -6.75% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | Peter E. Boyd | Chief People Officer | 29,814 | $4.17 | $599.9M | -36.69% | +63.14% | $124.4K | -7.26% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | Lori J Braender | Chief Legal Officer | 40,102 | $4.17 | $599.9M | -36.69% | +63.14% | $167.3K | -7.52% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | Cassie Jung | Chief Operating Officer | 45,791 | $4.17 | $599.9M | -36.69% | +63.14% | $191.1K | -12.61% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | A Ernest Jr Toth | Chief Financial Officer | 58,254 | $4.17 | $599.9M | -36.69% | +63.14% | $243.1K | -11.55% | — | Buy Now |
| Mar 10, 2026 | Sell | AQST | Daniel Barber | President and CEO | 180,677 | $4.17 | $599.9M | -36.69% | +63.14% | $754.0K | -10.58% | — | Buy Now |
| Dec 2, 2025 | Sell | AQST | Melina Cioffi | SVP, Regulatory Affairs | 2,083 | $5.93 | $599.9M | -36.69% | +63.14% | $12.4K | -1.03% | — | Buy Now |
| Oct 15, 2025 | Sell | AQST | Peter E. Boyd | — | 10,000 | $7.00 | $599.9M | -36.69% | +63.14% | $70.0K | -3.59% | 10b5-1 | Buy Now |
| Oct 15, 2025 | Sell | AQST | Carl N Kraus | Chief Medical Officer | 20,272 | $7.00 | $599.9M | -36.69% | +63.14% | $141.9K | -6.70% | 10b5-1 | Buy Now |
| Oct 15, 2025 | Sell | AQST | Cassie Jung | Chief Operating Officer | 92,575 | $5.95 | $599.9M | -36.69% | +63.14% | $551.3K | -7.20% | 10b5-1 | Buy Now |
| Sep 26, 2025 | Sell | AQST | Peter E. Boyd | — | 10,000 | $6.30 | $599.9M | -36.69% | +63.14% | $63.0K | -3.47% | 10b5-1 | Buy Now |
| Sep 26, 2025 | Sell | AQST | Daniel Barber | President and CEO | 91,343 | $6.03 | $599.9M | -36.69% | +63.14% | $551.2K | -9.00% | — | Buy Now |
| Sep 19, 2025 | Sell | AQST | Daniel Barber | President and CEO | 400 | $6.00 | $599.9M | -36.69% | +63.14% | $2.4K | -0.04% | — | Buy Now |
| Sep 5, 2025 | Sell | AQST | Peter E. Boyd | — | 15,000 | $5.30 | $599.9M | -36.69% | +63.14% | $79.5K | -4.95% | 10b5-1 | Buy Now |
| Sep 4, 2025 | Sell | AQST | Cassie Jung | Chief Operating Officer | 112,180 | $3.63 | $599.9M | -36.69% | +63.14% | $407.3K | -1.27% | 10b5-1 | Buy Now |
| Aug 9, 2025 | Sell | AQST | Carl N Kraus | Chief Medical Officer | 10,819 | $3.90 | $599.9M | -36.69% | +63.14% | $42.2K | -3.45% | — | Buy Now |
| Jun 9, 2025 | Sell | AQST | Sherry Korczynski | SVP Sales and Marketing | 2,714 | $3.54 | $599.9M | -36.69% | +63.14% | $9.6K | -1.70% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Sherry Korczynski | SVP Sales and Marketing | 5,428 | $2.65 | $599.9M | -36.69% | +63.14% | $14.4K | -2.71% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Carl N Kraus | Chief Medical Officer | 8,115 | $2.65 | $599.9M | -36.69% | +63.14% | $21.5K | -2.31% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Peter E. Boyd | See Remark | 14,305 | $2.65 | $599.9M | -36.69% | +63.14% | $37.9K | -2.14% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Cassie Jung | Chief Operating Officer | 17,540 | $2.64 | $599.9M | -36.69% | +63.14% | $46.2K | -1.83% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | A Ernest Jr Toth | Chief Financial Officer | 18,929 | $2.65 | $599.9M | -36.69% | +63.14% | $50.2K | -2.47% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Lori J Braender | Chief Legal Officer | 20,250 | $2.65 | $599.9M | -36.69% | +63.14% | $53.7K | -2.26% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Stephen Wargacki | Chief Science Officer | 32,862 | $2.63 | $599.9M | -36.69% | +63.14% | $86.6K | -2.85% | — | Buy Now |
| Mar 7, 2025 | Sell | AQST | Daniel Barber | President and CEO | 83,305 | $2.65 | $599.9M | -36.69% | +63.14% | $220.8K | -3.23% | — | Buy Now |
| Nov 26, 2024 | Sell | AQST | Cassie Jung | Chief Operating Officer | 44 | $4.87 | $599.9M | -36.69% | +63.14% | $214.06 | -100.00% | — | Buy Now |
| Aug 9, 2024 | Sell | AQST | Carl N Kraus | Chief Medical Officer | 10,819 | $3.43 | $599.9M | -36.69% | +63.14% | $37.1K | -4.12% | — | Buy Now |
| Mar 15, 2024 | Sell | AQST | Alexander Mark Schobel | Chief Innovation/Tech Officer | 50,000 | $6.00 | $599.9M | -36.69% | +63.14% | $300.0K | -4.83% | 10b5-1 | Buy Now |
| Mar 9, 2024 | Sell | AQST | Peter E. Boyd | See Remark | 8,370 | $4.88 | $599.9M | -36.69% | +63.14% | $40.8K | -3.40% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Cassie Jung | SVP, Operations | 9,432 | $4.88 | $599.9M | -36.69% | +63.14% | $46.0K | -1.94% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Alexander Mark Schobel | Chief Innovation/Tech Officer | 9,645 | $4.88 | $599.9M | -36.69% | +63.14% | $47.1K | -0.97% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Lori J Braender | SVP, General Counsel | 10,530 | $4.88 | $599.9M | -36.69% | +63.14% | $51.4K | -3.25% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | A Ernest Jr Toth | SVP, Chief Financial Officer | 11,705 | $4.88 | $599.9M | -36.69% | +63.14% | $57.1K | -4.50% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Stephen Wargacki | SVP, Research & Development | 12,956 | $4.88 | $599.9M | -36.69% | +63.14% | $63.2K | -2.44% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Cassie Jung | SVP, Operations | 14,120 | $4.88 | $599.9M | -36.69% | +63.14% | $68.9K | -5.71% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Stephen Wargacki | Chief Science Officer | 19,505 | $4.88 | $599.9M | -36.69% | +63.14% | $95.2K | -6.94% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Daniel Barber | President and CEO | 37,938 | $4.88 | $599.9M | -36.69% | +63.14% | $185.1K | -4.30% | — | Buy Now |
| Mar 9, 2024 | Sell | AQST | Daniel Barber | President and CEO | 56,824 | $4.88 | $599.9M | -36.69% | +63.14% | $277.3K | -6.43% | — | Buy Now |
| Mar 8, 2024 | Sell | AQST | Alexander Mark Schobel | Chief Innovation/Tech Officer | 30,895 | $5.13 | $599.9M | -36.69% | +63.14% | $158.5K | -1.47% | 10b5-1 | Buy Now |